Brie Carter

Shares of Eli Lilly (NYSE:LLY) rose 4% on Monday after the company unveiled highly anticipated clinical data for its next-generation obesity treatment, retatrutide.

Johnson & Johnson (NYSE:JNJ) announced today that it has entered into a definitive agreement to acquire Firefly Bio for $1 billion in cash.

RedHill Biopharma (NASDAQ:RDHL) announced on June 8, 2026, that it has officially commenced recognition and enforcement proceedings in South Korea to collect on a final judgment awarded by the New York Supreme Court against Kukbo.

AstroNova (NASDAQ:ALOT), a global leader in specialized print technology solutions, reported financial results for its fiscal 2027 first quarter ended April 30, 2026.

Duluth Holdings (NASDAQ:DLTH) reported financial results for the first quarter of fiscal 2026, ended May 3, 2026, highlighting significant progress in operational efficiency despite a challenging retail environment.

The return of the USD/JPY exchange rate above the 160 level has revived concerns that Japan could once again become a catalyst for turbulence across global financial markets, including cryptocurrencies.

Global oil markets faced heightened volatility on Monday as investors reacted to an escalation in regional conflict.

DWF Labs founder Andrei Grachev has warned that the growing concentration of Bitcoin and Ethereum in the hands of publicly listed companies could create the conditions for the largest crash in crypto market history.

Artiva Biotherapeutics (NASDAQ:ARTV) has shared encouraging clinical findings for its lead therapeutic candidate, AlloNK® (AB-101), during the European Alliance of Associations for Rheumatology (EULAR) 2026 congress.

The CLARITY Act's chances of becoming law in 2026 have fallen to 60% from 75%, according to Galaxy Digital, as lawmakers face a narrowing window to advance landmark crypto legislation before the Senate's August recess.